Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE791
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,939
Award facts
- Contract value 100% obligated
- $4,939.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,939.34 to AmerisourceBergen Drug Corp on December 11, 2025, under the Pharmaceutical PV (Prime Vendor) Division program. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and the work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems.
AmerisourceBergen holds a significant $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX) extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This prime contract enables the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The delivery order issued under this vehicle demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition, consistent with the DLA's Pharmaceutical Prime Vendor Global Program strategy, which plans to establish multiple regional contracts with different contractors to ensure flexible and comprehensive pharmaceutical support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DU26FE791?
SPE2DU26FE791 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DU26FE791 worth?
The government has obligated $4,939 on SPE2DU26FE791.
Is contract SPE2DU26FE791 an order under another contract?
Yes. SPE2DU26FE791 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE791 competed?
The extent of competition for SPE2DU26FE791 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award